CRM
BIO icon

Cramer Rosenthal McGlynn’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-64,289
Closed -$23M 105
2023
Q3
$23M Sell
64,289
-3,286
-5% -$1.18M 1.29% 31
2023
Q2
$25.6M Sell
67,575
-13,498
-17% -$5.12M 1.28% 32
2023
Q1
$38.8M Buy
81,073
+2,051
+3% +$982K 1.75% 16
2022
Q4
$33.2M Buy
79,022
+19,996
+34% +$8.41M 1.46% 23
2022
Q3
$24.6M Buy
59,026
+13,677
+30% +$5.71M 1.18% 34
2022
Q2
$22.4M Buy
45,349
+16,838
+59% +$8.33M 1.03% 40
2022
Q1
$16.1M Sell
28,511
-884
-3% -$498K 0.63% 62
2021
Q4
$22.2M Sell
29,395
-550
-2% -$416K 0.72% 60
2021
Q3
$22.3M Sell
29,945
-649
-2% -$484K 0.76% 52
2021
Q2
$19.7M Sell
30,594
-2,013
-6% -$1.3M 0.63% 63
2021
Q1
$18.6M Sell
32,607
-18,282
-36% -$10.4M 0.62% 61
2020
Q4
$29.7M Sell
50,889
-23,492
-32% -$13.7M 0.93% 40
2020
Q3
$38.3M Sell
74,381
-9,644
-11% -$4.97M 1.55% 25
2020
Q2
$37.9M Sell
84,025
-63,320
-43% -$28.6M 1.53% 26
2020
Q1
$51.7M Sell
147,345
-6,733
-4% -$2.36M 2.43% 6
2019
Q4
$57M Sell
154,078
-13,707
-8% -$5.07M 1.62% 17
2019
Q3
$55.8M Sell
167,785
-6,220
-4% -$2.07M 1.58% 16
2019
Q2
$54.4M Sell
174,005
-5,385
-3% -$1.68M 1.49% 19
2019
Q1
$54.8M Sell
179,390
-21,266
-11% -$6.5M 1.31% 25
2018
Q4
$46.6M Buy
200,656
+13,798
+7% +$3.2M 1.18% 32
2018
Q3
$58.5M Sell
186,858
-4,054
-2% -$1.27M 1.12% 32
2018
Q2
$55.1M Buy
190,912
+39,046
+26% +$11.3M 0.99% 40
2018
Q1
$38M Buy
151,866
+45,446
+43% +$11.4M 0.62% 75
2017
Q4
$25.4M Sell
106,420
-170,874
-62% -$40.8M 0.41% 88
2017
Q3
$61.6M Sell
277,294
-41,648
-13% -$9.25M 0.99% 31
2017
Q2
$72.2M Buy
318,942
+218,512
+218% +$49.5M 1.1% 23
2017
Q1
$20M Buy
+100,430
New +$20M 0.31% 112